A regular physical activity program reduced the amount of time older adults spent with a major mobility disability, according to recent research.
Northwestern Medicine scientists have identified a signaling pathway that regulates the behavior of two subtypes of glioblastomas.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
A 3-D printable ink developed by Northwestern scientists produces synthetic bone implants with unique properties to induce bone regeneration.
Northwestern University has been awarded a grant from the National Institutes of Health to help scientists across the country study how environmental factors influence health outcomes for children.
Dai Horiuchi, PhD, assistant professor of Pharmacology, has been awarded a $450,000 research grant from Susan G. Komen to explore a potential targeted therapy against triple-negative breast cancer.
Northwestern Medicine scientists continue to demonstrate that a protein called Hrd1 may be an important target for treating autoimmune diseases.
Huda Zoghbi, MD, recipient of the inaugural Mechthild Esser Nemmers Prize in Medical Science at Northwestern University, gave a presentation on her research journey studying the neurological disorder Rett syndrome.
Northwestern Medicine scientists utilized a data science approach to develop more efficient methodology that can be used to inform a wide variety of quality improvement strategies in clinical practices.
Northwestern Medicine scientists evaluated whether an RNA biosignature could distinguish if infants 60 days or younger with fever had a serious bacterial infection.